Health Ministry Proposes Regulatory Oversight for Antimicrobials
The Ministry of Health and Family Welfare has proposed an amendment to the New Drugs and Clinical Trials Rules, 2019, to include antimicrobials under regulatory oversight. This initiative aims to enhance the quality, safety, and efficacy of these drugs amid rising concerns over antimicrobial resistance (AMR). The draft notification, dated November 6, requires manufacturers to obtain permission from the Central Licensing Authority before applying for state-level manufacturing licenses. The ministry highlighted that the lack of adequate regulatory scrutiny could lead to the distribution of substandard antimicrobials, posing risks to patient safety. The proposal invites objections and suggestions from stakeholders before finalisation.
Published 2 days ago • 19 Nov 2026, 12:30 PM IST